Literature DB >> 28024868

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.

Ruta Sahasrabudhe1, Paul Lott1, Mabel Bohorquez2, Ted Toal1, Ana P Estrada2, John J Suarez2, Alejandro Brea-Fernández3, José Cameselle-Teijeiro4, Carla Pinto5, Irma Ramos6, Alejandra Mantilla7, Rodrigo Prieto2, Alejandro Corvalan8, Enrique Norero8, Carolina Alvarez9, Teresa Tapia9, Pilar Carvallo9, Luz M Gonzalez10, Alicia Cock-Rada10, Angela Solano11, Florencia Neffa12, Adriana Della Valle12, Chris Yau13, Gabriela Soares14, Alexander Borowsky15, Nan Hu16, Li-Ji He17, Xiao-You Han18, Philip R Taylor16, Alisa M Goldstein16, Javier Torres6, Magdalena Echeverry2, Clara Ruiz-Ponte3, Manuel R Teixeira19, Luis G Carvajal-Carmona20.   

Abstract

Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interaction; Stomach; Tumor; WES

Mesh:

Substances:

Year:  2016        PMID: 28024868      PMCID: PMC5367981          DOI: 10.1053/j.gastro.2016.12.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  MRG15 is a novel PALB2-interacting factor involved in homologous recombination.

Authors:  Shirley M-H Sy; Michael S Y Huen; Junjie Chen
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

2.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

3.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

4.  High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.

Authors:  Diana Torres; Muhammad Usman Rashid; Fabian Gil; Angela Umana; Giancarlo Ramelli; Jose Fernando Robledo; Mauricio Tawil; Lilian Torregrosa; Ignacio Briceno; Ute Hamann
Journal:  Breast Cancer Res Treat       Date:  2006-11-02       Impact factor: 4.872

5.  Family history and the risk of stomach and colorectal cancer.

Authors:  C La Vecchia; E Negri; S Franceschi; A Gentile
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Breast-cancer risk in families with mutations in PALB2.

Authors:  Antonis C Antoniou; William D Foulkes; Marc Tischkowitz
Journal:  N Engl J Med       Date:  2014-10-23       Impact factor: 91.245

8.  A mutational signature in gastric cancer suggests therapeutic strategies.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; Hoi Cheong Siu; Suet Yi Leung; Michael R Stratton
Journal:  Nat Commun       Date:  2015-10-29       Impact factor: 14.919

9.  Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.

Authors:  J-Y Park; T R Singh; N Nassar; F Zhang; M Freund; H Hanenberg; A R Meetei; P R Andreassen
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

10.  A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.

Authors:  Yuichi Shiraishi; Georg Tremmel; Satoru Miyano; Matthew Stephens
Journal:  PLoS Genet       Date:  2015-12-02       Impact factor: 5.917

View more
  43 in total

Review 1.  Resolving gastric cancer aetiology: an update in genetic predisposition.

Authors:  Paul C Lott; Luis G Carvajal-Carmona
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-12

2.  Clinical significance of RAD51C and its contribution to ovarian carcinogenesis.

Authors:  Xiao-Li Lu; Si-Sun Liu; Zhen-Fang Xiong; Fen Wang; Xia-Ying Li; Huan Deng
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 3.  Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.

Authors:  Ankur K Nagaraja; Osamu Kikuchi; Adam J Bass
Journal:  Cancer Discov       Date:  2019-11-14       Impact factor: 39.397

Review 4.  Hereditary gastric cancer: what's new? Update 2013-2018.

Authors:  Rachel S van der Post; Carla Oliveira; Parry Guilford; Fátima Carneiro
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

Review 5.  Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.

Authors:  Yoshiaki Nakamura; Akihito Kawazoe; Florian Lordick; Yelena Y Janjigian; Kohei Shitara
Journal:  Nat Rev Clin Oncol       Date:  2021-03-31       Impact factor: 66.675

6.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 7.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

Review 8.  Hereditary diffuse gastric cancer: updated clinical practice guidelines.

Authors:  Vanessa R Blair; Maybelle McLeod; Fátima Carneiro; Daniel G Coit; Johanna L D'Addario; Jolanda M van Dieren; Kirsty L Harris; Nicoline Hoogerbrugge; Carla Oliveira; Rachel S van der Post; Julie Arnold; Patrick R Benusiglio; Tanya M Bisseling; Alex Boussioutas; Annemieke Cats; Amanda Charlton; Karen E Chelcun Schreiber; Jeremy L Davis; Massimiliano di Pietro; Rebecca C Fitzgerald; James M Ford; Kimberley Gamet; Irene Gullo; Richard H Hardwick; David G Huntsman; Pardeep Kaurah; Sonia S Kupfer; Andrew Latchford; Paul F Mansfield; Takeshi Nakajima; Susan Parry; Jeremy Rossaak; Haruhiko Sugimura; Magali Svrcek; Marc Tischkowitz; Toshikazu Ushijima; Hidetaka Yamada; Han-Kwang Yang; Adrian Claydon; Joana Figueiredo; Karyn Paringatai; Raquel Seruca; Nicola Bougen-Zhukov; Tom Brew; Simone Busija; Patricia Carneiro; Lynn DeGregorio; Helen Fisher; Erin Gardner; Tanis D Godwin; Katharine N Holm; Bostjan Humar; Caroline J Lintott; Elizabeth C Monroe; Mark D Muller; Enrique Norero; Yasmin Nouri; Joana Paredes; João M Sanches; Emily Schulpen; Ana S Ribeiro; Andrew Sporle; James Whitworth; Liying Zhang; Anthony E Reeve; Parry Guilford
Journal:  Lancet Oncol       Date:  2020-08       Impact factor: 41.316

9.  Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.

Authors:  Thomas Slavin; Susan L Neuhausen; Christina Rybak; Ilana Solomon; Bita Nehoray; Kathleen Blazer; Mariana Niell-Swiller; Aaron W Adamson; Yate-Ching Yuan; Kai Yang; Sharon Sand; Danielle Castillo; Josef Herzog; Xiwei Wu; Shu Tao; Tanya Chavez; Yanghee Woo; Joseph Chao; Pamela Mora; Darling Horcasitas; Jeffrey Weitzel
Journal:  Cancer Genet       Date:  2017-08-17

10.  Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Authors:  Xin Yang; Goska Leslie; Alicja Doroszuk; Sandra Schneider; Jamie Allen; Brennan Decker; Alison M Dunning; James Redman; James Scarth; Inga Plaskocinska; Craig Luccarini; Mitul Shah; Karen Pooley; Leila Dorling; Andrew Lee; Muriel A Adank; Julian Adlard; Kristiina Aittomäki; Irene L Andrulis; Peter Ang; Julian Barwell; Jonine L Bernstein; Kristie Bobolis; Åke Borg; Carl Blomqvist; Kathleen B M Claes; Patrick Concannon; Adeline Cuggia; Julie O Culver; Francesca Damiola; Antoine de Pauw; Orland Diez; Jill S Dolinsky; Susan M Domchek; Christoph Engel; D Gareth Evans; Florentia Fostira; Judy Garber; Lisa Golmard; Ellen L Goode; Stephen B Gruber; Eric Hahnen; Christopher Hake; Tuomas Heikkinen; Judith E Hurley; Ramunas Janavicius; Zdenek Kleibl; Petra Kleiblova; Irene Konstantopoulou; Anders Kvist; Holly Laduca; Ann S G Lee; Fabienne Lesueur; Eamonn R Maher; Arto Mannermaa; Siranoush Manoukian; Rachel McFarland; Wendy McKinnon; Alfons Meindl; Kelly Metcalfe; Nur Aishah Mohd Taib; Jukka Moilanen; Katherine L Nathanson; Susan Neuhausen; Pei Sze Ng; Tu Nguyen-Dumont; Sarah M Nielsen; Florian Obermair; Kenneth Offit; Olufunmilayo I Olopade; Laura Ottini; Judith Penkert; Katri Pylkäs; Paolo Radice; Susan J Ramus; Vilius Rudaitis; Lucy Side; Rachel Silva-Smith; Valentina Silvestri; Anne-Bine Skytte; Thomas Slavin; Jana Soukupova; Carlo Tondini; Alison H Trainer; Gary Unzeitig; Lydia Usha; Thomas van Overeem Hansen; James Whitworth; Marie Wood; Cheng Har Yip; Sook-Yee Yoon; Amal Yussuf; George Zogopoulos; David Goldgar; John L Hopper; Georgia Chenevix-Trench; Paul Pharoah; Sophia H L George; Judith Balmaña; Claude Houdayer; Paul James; Zaki El-Haffaf; Hans Ehrencrona; Marketa Janatova; Paolo Peterlongo; Heli Nevanlinna; Rita Schmutzler; Soo-Hwang Teo; Mark Robson; Tuya Pal; Fergus Couch; Jeffrey N Weitzel; Aaron Elliott; Melissa Southey; Robert Winqvist; Douglas F Easton; William D Foulkes; Antonis C Antoniou; Marc Tischkowitz
Journal:  J Clin Oncol       Date:  2019-12-16       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.